D.E. Shaw & Co
OSIR

D.E. Shaw & Co’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-140,978
Closed -$692K 2774
2016
Q4
$692K Buy
140,978
+32,808
+30% +$161K ﹤0.01% 1907
2016
Q3
$537K Sell
108,170
-3,388
-3% -$16.8K ﹤0.01% 1978
2016
Q2
$568K Buy
111,558
+14,937
+15% +$76.1K ﹤0.01% 2018
2016
Q1
$552K Buy
96,621
+77,465
+404% +$443K ﹤0.01% 2024
2015
Q4
$199K Sell
19,156
-50,339
-72% -$523K ﹤0.01% 2434
2015
Q3
$1.28M Sell
69,495
-54,608
-44% -$1.01M ﹤0.01% 1599
2015
Q2
$2.42M Buy
124,103
+57,499
+86% +$1.12M ﹤0.01% 1385
2015
Q1
$1.17M Buy
66,604
+52,818
+383% +$929K ﹤0.01% 1664
2014
Q4
$220K Buy
+13,786
New +$220K ﹤0.01% 2303
2014
Q3
Sell
-10,653
Closed -$166K 2833
2014
Q2
$166K Buy
+10,653
New +$166K ﹤0.01% 2221
2014
Q1
Sell
-10,418
Closed -$168K 2822
2013
Q4
$168K Sell
10,418
-9,448
-48% -$152K ﹤0.01% 2336
2013
Q3
$331K Buy
19,866
+657
+3% +$10.9K ﹤0.01% 2055
2013
Q2
$193K Buy
+19,209
New +$193K ﹤0.01% 2182